SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-028659
Filing Date
2022-08-15
Accepted
2022-08-15 17:46:32
Documents
2
Period of Report
2022-08-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2270
2 EX-24 DOCUMENT attachment1.htm EX-24 5994
  Complete submission text file 0000899243-22-028659.txt   9797
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALAUNOS THERAPEUTICS, INC. 8030 EL RIO ST. HOUSTON TX 77054
Business Address
Srivastava Abhishek K (Reporting) CIK: 0001941863 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33038 | Film No.: 221167111